Postchallenge hyperglycemia in a national sample of U.S. adults with type 2 diabetes

Diabetes Care

Volumn 24, Issue 10, 2001, Pages 1734-1738

  Erlinger, Thomas P ^a,c   Brancati, Frederick L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FOOD; GLUCOSE TOLERANCE TEST; HUMAN; HYPERGLYCEMIA; KINETICS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FOOD; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; KINETICS; MIDDLE AGED; SULFONYLUREA COMPOUNDS;

EID: 0035489475     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.10.1734     Document Type: Article

References (27)

1. Geiss LS, Herman WH, Smith PJ: Mortality in non-insulin-dependent diabetes. In Diabetes in America. National Diabetes Data Group, Eds., Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995, p. 233-258 (NIH publ. no. 95-1468)
2. Complications of Diabetes, In Diabetes in America. National Diabetes Data Group, Eds., Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995, p. 259-507 (NIH publ. no. 95-1468)
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977-986, 1993
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33): UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:837-853, 1998
5. Davidson MB, Schriger DL, Peters AL, Lorber B: Revisiting the oral glucose tolerance test criterion for the diagnosis of diabetes. J Gen Intern Med 15:551-555, 2000
6. Horion ES, Clinkingbeard C, Gatlin M, Foley J, Mallows S, Shen S: Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes. Diabetes Care 23:1660-1665, 2000
7. Barrett-Connor E, Ferrara A: Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men: the Rancho Bernardo Study. Diabetes Care 21:1236-1239, 1998
8. Hanefeld M, Koehler C, Schaper F, Fuecker K, Henkel E, Temelkova-Kurktschiev T: Postprandial plasma glucose is an inde-pendent risk factor for increased carotid intima-media thickness in non-diabetic individuals. Atherosclerosis 144:229-235, 1999
9. Kuizon D, Gordon SM, Dolmatch BL: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397-405, 2001
10. Clark MJ Jr, Sterrett JJ, Carson DS: Diabetes guidelines: a summary and comparison of the recommendations of the American Diabetes Association, Veterans Health Administration, and American Association of Clinical Endocrinologists. Clin Ther 22:899-910, 2000
11. Harris MI, Cowie CC, Howie LJ: Self-monitoring of blood glucose by adults with diabetes in the United States population. Diabetes Care 16:1116-1123, 1993
12. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey 1988-1994. Diabetes Care 21:518-524, 1998
13. Third National Health and Nutrition Examination Survey, 1988-1994, Reference Manuals and Reports: Manual for Medical Technicians and Laboratory Procedures Used for NHANES III Bethesda, MD, National Center for Health Statistics, 1996 (CD-ROM)
14. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
15. American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care 21 (Suppl. 1):523-531, 1998
16. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, Marks JS: Diabetes trends in the U.S.: 1990-1998. Diabetes Care 23:1278-1283, 2000
17. Jackson RA, Blix PM, Matthews JA, Morgan LM, Rubenstein AH, Nabarro JD: Comparison of peripheral glucose uptake after oral glucose loading and a mixed meal. Metabolism 32:706-710, 1983
18. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS: Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 22:403-408, 1999
19. Lefebvre PJ, Scheen AJ: The postprandial state and risk of cardiovascular disease. Diabet Med 15 (Suppl. 4):S63-S68, 1998
20. Jarrett RJ: The cardiovascular risk associated with impaired glucose tolerance. Diabet Med 13:S15-S19, 1996
21. Peters AL, Davidson MB, Schriger DL, Hasselblad V: A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels: Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. JAMA 276:1246-1252, 1996
22. de Vegt F, Dekker JM, Stehouwer CD, Nij pels G, Bouter LM, Heine RJ: The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. Diabetes Care 21:1686-1690, 1998
23. Jeppesen J, Zhou MY, Chen YD, Reaven GM: Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM. Diabetes Care 17:1093-1099, 1994
24. Weyer C, Bogardus C, Mott DM, Pratley RE: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794, 1999
25. DeFronzo RA: Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 131:281-303, 1999
26. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 354:617-621, 1999
27. Holman RR, Cull CA, Turner RC: A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44). Diabetes Care 22:960-964, 1999